also suggest discussing pregnancy plans prior to initiating treatment with medications that may affect gonadal function, such as CYC. There are no published data regarding specific timing for medication discussion, which will vary according to the individual clinical situation, but in general we suggest adequate time to allow for appropriate medication changes and demonstration of tolerability and disease stability, usually a minimum of several months. MTX, MMF, CYC, and thalidomide are known